{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0030154",
      "entity_text" : "differentiation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04543",
      "entity_text" : "fraxetin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The current results demonstrated that fraxetin administration prevented Ti particle induced osteolysis in a mouse osteolysis model and did not result in any obvious side effects, confirming that fraxetin inhibits osteoclast differentiation and function in vivo and suggesting that it may hold potential therapeutic benefits on PO.",
  "reading_complete" : "2020-08-03T17:37:34Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:36:57Z",
  "trigger" : "inhibits",
  "evidence" : [ "fraxetin inhibits osteoclast differentiation" ],
  "pmc_id" : "6089765",
  "score" : 0
}